Literature DB >> 21316667

Clinical feasibility of direct peroral cholangioscopy-guided photodynamic therapy for inoperable cholangiocarcinoma performed by using an ultra-slim upper endoscope (with videos).

Hyun Jong Choi1, Jong Ho Moon, Bong Min Ko, Seul Ki Min, A Ri Song, Tae Hoon Lee, Young Koog Cheon, Young Deok Cho, Sang-Heum Park.   

Abstract

BACKGROUND: Photodynamic therapy (PDT) has emerged as a promising palliative treatment for inoperable cholangiocarcinoma. Cholangioscopy-guided PDT can be useful for identification of tumor margins, determination of the appropriate location for placement of the diffuser, and evaluation of the patient's response to therapy.
OBJECTIVE: To evaluate the feasibility of PDT under direct peroral cholangioscopy (POC) by using an ultra-slim upper endoscope in patients with inoperable cholangiocarcinoma.
DESIGN: Prospective, observational, pilot study.
SETTING: Single tertiary-care referral center. PATIENTS: This study involved 9 patients with inoperable extrahepatic cholangiocarcinoma. INTERVENTION: Photofrin II was administered intravenously 48 hours before PDT. Additional PDT was performed up to 48 hours after the initial application of therapy. A successful direct POC-guided PDT was defined as advancement of the endoscope into the distal margin of the tumor and maintenance of endoscope position until PDT was completed. MAIN OUTCOME MEASUREMENTS: The clinical feasibility, usefulness, and complications of direct POC for PDT.
RESULTS: Seventeen sessions of direct POC for PDT were performed in 9 patients. PDT was performed successfully in 15 of 17 sessions (88.2%) and 7 of 9 patients (77.8%). Biliary drainage under direct POC, if necessary after PDT, was possible in 100% of patients (7/7). Follow-up direct POC confirmed significant tumor ablation after PDT in 5 patients. One patient reported mild skin redness; no major procedure-related complications were observed. LIMITATIONS: Small sample size, pilot study.
CONCLUSION: Direct POC-guided PDT by using an ultra-slim upper endoscope seems to be both feasible and safe in select patients with inoperable extrahepatic cholangiocarcinoma.
Copyright © 2011 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21316667     DOI: 10.1016/j.gie.2010.11.049

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  11 in total

1.  Two cases of bile duct carcinoma patients who underwent the photodynamic therapy using talaporfin sodium (Laserphyrin®).

Authors:  Atsushi Nanashima; Masahide Hiyoshi; Naoya Imamura; Takeomi Hamada; Takahiro Nishida; Hiroshi Kawakami; Tesshin Ban; Yoshimasa Kubota; Koji Nakashima; Koichi Yano; Takashi Wada; Shinsuke Takeno; Masahiro Kai
Journal:  Clin J Gastroenterol       Date:  2019-06-20

Review 2.  Cholangioscopy in the digital era.

Authors:  Fares Ayoub; Dennis Yang; Peter V Draganov
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-29

Review 3.  Endoscopic treatment options for cholangiocarcinoma.

Authors:  Linda Ann Hou; Jacques Van Dam
Journal:  Hepat Oncol       Date:  2014-03-20

4.  How to access photodynamic therapy for bile duct carcinoma.

Authors:  Atsushi Nanashima; Hajime Isomoto; Takafumi Abo; Takashi Nonaka; Tomohito Morisaki; Junichi Arai; Katsunori Takagi; Ken Ohnita; Hiroyuki Shoji; Shigetoshi Urabe; Takemasa Senoo; Goshi Murakami; Takeshi Nagayasu
Journal:  Ann Transl Med       Date:  2014-03

5.  Photodynamic therapy for biliary tract organ via a novel ultra-small composite optical fiberscope.

Authors:  Kazuhiko Kasuya; Kiyoshi Oka; Ryoko Soya; Takaaki Tsuchiya; Takao Itoi; Akihiko Tsuchida
Journal:  Exp Ther Med       Date:  2017-08-28       Impact factor: 2.447

6.  A new peroral mother-baby endoscope system for biliary tract disorders.

Authors:  Christian Prinz; Andreas Weber; Stefanie Goecke; Bruno Neu; Alexander Meining; Eckart Frimberger
Journal:  World J Gastrointest Endosc       Date:  2014-01-16

7.  [Cholangioscopy].

Authors:  G Terheggen; H Neuhaus
Journal:  Internist (Berl)       Date:  2013-03       Impact factor: 0.743

8.  Photodynamic therapy in unresectable cholangiocarcinoma: not for the uncommitted.

Authors:  Jayant P Talreja; Marisa Degaetani; Kristi Ellen; Timothy Schmitt; Monica Gaidhane; Michel Kahaleh
Journal:  Clin Endosc       Date:  2013-07-31

9.  A powerful combination of copper-cysteamine nanoparticles with potassium iodide for bacterial destruction.

Authors:  Xiumei Zhen; Lalit Chudal; Nil Kanatha Pandey; Jonathan Phan; Xin Ran; Eric Amador; Xuejing Huang; Omar Johnson; Yuping Ran; Wei Chen; Michael R Hamblin; Liyi Huang
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2020-01-11       Impact factor: 7.328

10.  Clinical evaluation of a prototype multi-bending peroral direct cholangioscope.

Authors:  Takao Itoi; D Nageshwar Reddy; Atsushi Sofuni; Mohan Ramchandani; Fumihide Itokawa; Rajesh Gupta; Toshio Kurihara; Takayoshi Tsuchiya; Kentaro Ishii; Nobuhito Ikeuchi; Fuminori Moriyasu; Jong Ho Moon
Journal:  Dig Endosc       Date:  2013-04-07       Impact factor: 7.559

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.